Log in to save to my catalogue

Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-o...

Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_61c440be3029403faa4a07ceae0b4e4f

Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation

About this item

Full title

Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation

Publisher

England: BioMed Central Ltd

Journal title

BMC immunology, 2021-03, Vol.22 (1), p.19-19, Article 19

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

We aimed to report the clinical characteristics, immunological features, and treatment of one patient with a de novo STAT3 gain-of-function mutation identified by next generation sequencing. We investigated the efficacy of tocilizumab therapy in immune dysregulation diseases caused by STAT3 mutation.
The patient was a 16-year-old girl. She prese...

Alternative Titles

Full title

Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_61c440be3029403faa4a07ceae0b4e4f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_61c440be3029403faa4a07ceae0b4e4f

Other Identifiers

ISSN

1471-2172

E-ISSN

1471-2172

DOI

10.1186/s12865-021-00411-1

How to access this item